Register entry

SUCAMPO PHARMA LIMITED LIABILITY COMPANY

Data as of · How to read this entry

Registered sites
0
Active NDC listings
2
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

2

2 active NDC listings: 2 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 2.

Dosage formNDCs
solution, concentrate2
RouteNDCs
Labeller name on the listingNDCs
sucampo pharma limited liability company2
Catalogue

Marketed products

2
BrandGeneric nameForm / routeNDC
-Lubiprostone Premixsolution, concentrate13299-0102DRUG FOR FURTHER PROCESSING
-Lubiprostone Premixsolution, concentrate13299-0104DRUG FOR FURTHER PROCESSING
Enquiry

Common questions

Is SUCAMPO PHARMA LIMITED LIABILITY COMPANY FDA approved?
SUCAMPO PHARMA LIMITED LIABILITY COMPANY holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does SUCAMPO PHARMA LIMITED LIABILITY COMPANY make?
2 products are listed under SUCAMPO PHARMA LIMITED LIABILITY COMPANY in the openFDA NDC Directory, most often as solution, concentrate. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.